We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-0.84%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.48B
AUM Growth
+$119M
(+5%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
6.35%
Top 10 Holdings %
Top 10 Hldgs %
35.06%
Holding
3,425
New
363
Increased
1,606
Reduced
626
Closed
190
Avg Time Held Equity + Options
2.6
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
2.1
years
Avg Time Held Equity only
2.6
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$24.8M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$24.7M |
| 3 |
iShares Core US REIT ETF
USRT
|
+$23.7M |
| 4 |
Coupang
CPNG
|
+$22M |
| 5 |
FTOC
FTAC Olympus Acquisition Corp. Class A Ordinary Shares
FTOC
|
+$15.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Medical Devices ETF
IHI
|
+$15.9M |
| 2 |
iShares Global Tech ETF
IXN
|
+$14.7M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$9.94M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$3.22M |
| 5 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.99% |
| 2 | Technology | 15.91% |
| 3 | Financials | 8.1% |
| 4 | Healthcare | 5.94% |
| 5 | Consumer Discretionary | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
Corteva
CTVA
$8.59B
| $700K | 0.03% |
16,636
-53
| -0.3% | -$2.29K |
2019 Q3
8 quarters
|
|
327
iShares Biotechnology ETF
IBB
$10.6B
| $700K | 0.03% |
4,329
-31
| -0.7% | -$5.22K |
2016 Q4
19 quarters
|
|
328
iShares US Aerospace & Defense ETF
ITA
$12B
| $691K | 0.03% |
6,631
-229
| -3% | -$24.3K |
2016 Q4
19 quarters
|
|
329
Accuray
ARAY
$20.8M
| $690K | 0.03% |
174,701
-234
| -0.1% | -$929 |
2019 Q3
8 quarters
|
|
330
Roper Technologies
ROP
$37.8B
| $685K | 0.03% |
1,535
+596
| +63% | +$286K |
2016 Q4
19 quarters
|
|
331
Prologis
PLD
$121B
| $683K | 0.03% |
5,447
+709
| +15% | +$92K |
2016 Q4
19 quarters
|
|
332
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.3B
| $683K | 0.03% |
16,063
-261
| -2% | -$11.3K |
2019 Q2
9 quarters
|
|
333
TJX Companies
TJX
$159B
| $682K | 0.03% |
10,341
+1,511
| +17% | +$105K |
2016 Q4
19 quarters
|
|
334
Charter Communications
CHTR
$12.6B
| $681K | 0.03% |
936
+138
| +17% | +$105K |
2016 Q4
19 quarters
|
|
335
iShares 1-3 Year Treasury Bond ETF
SHY
$26.8B
| $679K | 0.03% |
7,884
-7,210
| -48% | -$622K |
2016 Q4
19 quarters
|
|
336
Eaton
ETN
$156B
| $678K | 0.03% |
4,543
+372
| +9% | +$59.5K |
2016 Q4
19 quarters
|
|
|
RDS.A
337
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $669K | 0.03% |
15,017
+2,357
| +19% | +$95.1K |
2016 Q4
19 quarters
|
|
338
Delta Air Lines
DAL
$51.4B
| $665K | 0.03% |
15,606
-511
| -3% | -$20.9K |
2016 Q4
19 quarters
|
|
339
Marsh
MRSH
$89B
| $664K | 0.03% |
4,383
+501
| +13% | +$75.8K |
2016 Q4
19 quarters
|
|
340
Schwab US Mid-Cap ETF
SCHM
$14.6B
| $661K | 0.03% |
25,875
+72
| +0.3% | +$1.88K |
2017 Q2
17 quarters
|
|
341
Zoom
ZM
$28.7B
| $661K | 0.03% |
2,529
-1,062
| -30% | -$358K |
2019 Q3
8 quarters
|
|
342
Marvell Technology
MRVL
$217B
| $653K | 0.03% |
10,828
+3,184
| +42% | +$191K |
2019 Q2
9 quarters
|
|
343
Sea Limited
SE
$59.7B
| $652K | 0.03% |
2,047
+78
| +4% | +$23.9K |
2020 Q2
5 quarters
|
|
344
Lincoln National
LNC
$7.66B
| $647K | 0.03% |
9,409
+3,288
| +54% | +$215K |
2016 Q4
19 quarters
|
|
345
Lam Research
LRCX
$347B
| $645K | 0.03% |
11,330
+1,010
| +10% | +$61.4K |
2016 Q4
19 quarters
|
|
346
Prudential Financial
PRU
$40.1B
| $642K | 0.03% |
6,104
+621
| +11% | +$64K |
2016 Q4
19 quarters
|
|
347
Regeneron Pharmaceuticals
REGN
$82B
| $631K | 0.03% |
1,042
+441
| +73% | +$274K |
2016 Q4
19 quarters
|
|
348
Church & Dwight Co
CHD
$24.5B
| $629K | 0.03% |
7,615
+1,886
| +33% | +$160K |
2016 Q4
19 quarters
|
|
349
Essex Property Trust
ESS
$17.3B
| $625K | 0.03% |
1,955
+7
| +0.4% | +$2.27K |
2016 Q4
19 quarters
|
|
350
CSX Corp
CSX
$90.2B
| $622K | 0.03% |
20,900
+1,114
| +6% | +$35.7K |
2016 Q4
19 quarters
|
|
Similar funds
Parallel Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Parallel Advisors held 3,425 positions worth $2.48B, up 5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Parallel Advisors deployed $158M of net new capital in Q3 2021, opening 363 new positions and adding to 1,606 existing holdings. Its largest new stake was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 53% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares US Medical Devices ETF, an estimated $15.9M trimmed.
- Parallel Advisors's largest Q3 2021 buy was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
- Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q3 2021, an estimated $24.8M increase.
- Parallel Advisors's biggest Q3 2021 reduction was iShares US Medical Devices ETF, cutting an estimated $15.9M.
- Parallel Advisors fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $1.71M.
- Parallel Advisors's ten largest holdings make up 35% of its $2.48B portfolio in Q3 2021.
- Parallel Advisors opened 363 new positions and closed 190 in Q3 2021.
- Parallel Advisors's portfolio value rose 5% quarter-over-quarter to $2.48B.
Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.